Tara B Hendry-Hofer1, Patrick C Ng1,2, Alison M McGrath3, Kirsten Soules1, David S Mukai4, Adriano Chan5, Joseph K Maddry6, Carl W White7, Jangwoen Lee4, Sari B Mahon4, Matthew Brenner4, Gerry R Boss5, Vikhyat S Bebarta1,6. 1. Department of Emergency Medicine, University of Colorado, Aurora, CO, USA. 2. Brooke Army Medical Center, Ft Sam Houston, San Antonio, Texas. 3. Department of Environmental Health and Safety, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 4. Beckman Laser Institute, University of California, Irvine, CA, USA. 5. Department of Medicine, University of California, La Jolla, CA, USA. 6. 59th Medical Wing/Science & Technology, Lackland Air Force Base, Texas, San Antonio Military Medical Center, JBSA-Ft Sam Houston, San Antonio, Texas. 7. Department of Pediatrics, University of Colorado, Aurora, CO, USA.
Abstract
BACKGROUND: Methyl mercaptan occurs naturally in the environment and is found in a variety of occupational settings, including the oil, paper, plastics, and pesticides industries. It is a toxic gas and deaths from methyl mercaptan exposure have occurred. The Department of Homeland Security considers it a high threat chemical agent that could be used by terrorists. Unfortunately, no specific treatment exists for methyl mercaptan poisoning. METHODS: We conducted a randomized trial in 12 swine comparing no treatment to intramuscular injection of the vitamin B12 analog cobinamide (2.0 mL, 12.5 mg/kg) following acute inhalation of methyl mercaptan gas. Physiological and laboratory parameters were similar in the control and cobinamide-treated groups at baseline and at the time of treatment. RESULTS: All six cobinamide-treated animals survived, whereas only one of six control animals lived (17% survival) (p = 0.0043). The cobinamide-treated animals returned to a normal breathing pattern by 3.8 ± 1.1 min after treatment (mean ± SD), while all but one animal in the control group had intermittent gasping, never regaining a normal breathing pattern. Blood pressure and arterial oxygen saturation returned to baseline values within 15 minutes of cobinamide-treatment. Plasma lactate concentration increased progressively until death (10.93 ± 6.02 mmol [mean ± SD]) in control animals, and decreased toward baseline (3.79 ± 2.93 mmol [mean ± SD]) by the end of the experiment in cobinamide-treated animals. CONCLUSION: We conclude that intramuscular administration of cobinamide improves survival and clinical outcomes in a large animal model of acute, high dose methyl mercaptan poisoning.
BACKGROUND: Methyl mercaptan occurs naturally in the environment and is found in a variety of occupational settings, including the oil, paper, plastics, and pesticides industries. It is a toxic gas and deaths from methyl mercaptan exposure have occurred. The Department of Homeland Security considers it a high threat chemical agent that could be used by terrorists. Unfortunately, no specific treatment exists for methyl mercaptan poisoning. METHODS: We conducted a randomized trial in 12 swine comparing no treatment to intramuscular injection of the vitamin B12 analog cobinamide (2.0 mL, 12.5 mg/kg) following acute inhalation of methyl mercaptan gas. Physiological and laboratory parameters were similar in the control and cobinamide-treated groups at baseline and at the time of treatment. RESULTS: All six cobinamide-treated animals survived, whereas only one of six control animals lived (17% survival) (p = 0.0043). The cobinamide-treated animals returned to a normal breathing pattern by 3.8 ± 1.1 min after treatment (mean ± SD), while all but one animal in the control group had intermittent gasping, never regaining a normal breathing pattern. Blood pressure and arterial oxygen saturation returned to baseline values within 15 minutes of cobinamide-treatment. Plasma lactate concentration increased progressively until death (10.93 ± 6.02 mmol [mean ± SD]) in control animals, and decreased toward baseline (3.79 ± 2.93 mmol [mean ± SD]) by the end of the experiment in cobinamide-treated animals. CONCLUSION: We conclude that intramuscular administration of cobinamide improves survival and clinical outcomes in a large animal model of acute, high dose methyl mercaptan poisoning.
Authors: K Korhonen; T Liukkonen; W Ahrens; G Astrakianakis; P Boffetta; A Burdorf; D Heederik; T Kauppinen; M Kogevinas; P Osvoll; B A Rix; A Saalo; J Sunyer; I Szadkowska-Stanczyk; K Teschke; H Westberg; K Widerkiewicz Journal: Int Arch Occup Environ Health Date: 2004-09-10 Impact factor: 3.015
Authors: Jangwoen Lee; Sari B Mahon; David Mukai; Tanya Burney; Behdod S Katebian; Adriano Chan; Vikhyat S Bebarta; David Yoon; Gerry R Boss; Matthew Brenner Journal: J Med Toxicol Date: 2016-09-15
Authors: Vikhyat S Bebarta; Normalynn Garrett; Matthew Brenner; Sari B Mahon; Joseph K Maddry; Susan Boudreau; Maria Castaneda; Gerry R Boss Journal: Acad Emerg Med Date: 2017-08-09 Impact factor: 3.451
Authors: Patrick C Ng; Tara B Hendry-Hofer; Norma Garrett; Matthew Brenner; Sari B Mahon; Joseph K Maddry; Philippe Haouzi; Gerry R Boss; Thomas F Gibbons; Allyson A Araña; Vikhyat S Bebarta Journal: Clin Toxicol (Phila) Date: 2018-11-15 Impact factor: 4.467
Authors: Denis S Salnikov; Sergei V Makarov; Rudi van Eldik; Polina N Kucherenko; Gerry R Boss Journal: Eur J Inorg Chem Date: 2014-09 Impact factor: 2.524
Authors: Patrick C Ng; Tara B Hendry-Hofer; Alyssa E Witeof; Matthew Brenner; Sari B Mahon; Gerry R Boss; Philippe Haouzi; Vikhyat S Bebarta Journal: J Med Toxicol Date: 2019-05-06
Authors: Vikhyat S Bebarta; David A Tanen; Susan Boudreau; Maria Castaneda; Lee A Zarzabal; Toni Vargas; Gerry R Boss Journal: Ann Emerg Med Date: 2014-04-18 Impact factor: 5.721
Authors: Tara B Hendry-Hofer; Patrick C Ng; Alison M McGrath; David Mukai; Matthew Brenner; Sari Mahon; Joseph K Maddry; Gerry R Boss; Vikhyat S Bebarta Journal: Ann N Y Acad Sci Date: 2020-03-31 Impact factor: 5.691
Authors: Anna J Esser; Srijan Mukherjee; Ilia A Dereven'kov; Sergei V Makarov; Donald W Jacobsen; Ute Spiekerkoetter; Luciana Hannibal Journal: iScience Date: 2022-08-18
Authors: Adriano Chan; Jangwoen Lee; Subrata Bhadra; Nesta Bortey-Sam; Tara B Hendry-Hofer; Vikhyat S Bebarta; Sari B Mahon; Matthew Brenner; Brian Logue; Renate B Pilz; Gerry R Boss Journal: Clin Toxicol (Phila) Date: 2021-07-30 Impact factor: 4.467